The prevalence and pathogenesis of portal vein thrombosis (PVT) in patients with cirrhosis without hepatocellular carcinoma are not clearly defined. The role of thrombophilic genetic factors is well established in other venous thrombotic diseases, as well as in noncirrhotic portal thrombosis. Recent
Inherited trombophilic disorders in patients with portal vein thrombosis
β Scribed by L. Amitrano; M.A. Guardascione; V. Brancaccio; M. Margaglione; P.R.J. Ames; G. D'Andrea; L. Iannaccone; A. Balzano
- Book ID
- 119526176
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 141 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In a prospective study of 33 adults with portal vein thrombosis unrelated to a liver tumor, we have assessed the prevalence of primary myeloproliferative disorders using conventional criteria and cultures of bone marrow progenitor cells. A primary myeloproliferative disorder was documented in 14 pat
The effects of occlusive portal vein thrombosis (PVT) on the survival of patients with cirrhosis are unknown. This was a retrospective cohort study at a single center. The main exposure variable was the presence of occlusive PVT. The primary outcome measure was time-dependent mortality. A total of 3